FDA approves Pfizer COVID-19 booster for older Americans and people at-risk
WASHINGTON — The U.S. Food and Drug Administration on Wednesday authorized a booster dose of the Pfizer and BioNTech COVID-19 vaccine for those 65 and older, all people at high risk of severe disease, and others who are regularly exposed to the virus. The decision paves the way for a quick rollout of the booster